Notice: This company recently went public with an IPO on Friday, September 13th 2024. They issued 13,235,294 shares at $17.00 per share. We will continue to update data for ZBIO as it becomes available. NASDAQ:ZBIO ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisOptions ChainTrends Get ProShares UltraPro Short Nasdaq Biotechnology alerts: Email Address About ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) 30 days 90 days 365 days Advanced Chart Ad InvestorPlaceWhy You Should NOT Trade This MarketYou'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go Get ZBIO alerts:Sign Up Key Stats Today's Range$17.50▼$18.0750-Day Range$10.02▼$10.0952-Week Range$8.28▼$18.64Volume70,142 shsAverage Volume32,378 shsMarket Capitalization$4.48 millionAssets Under Management$2.85 millionDividend Yield0.17%Net Expense Ratio0.95%Aggregate RatingN/A ETF OverviewRead More… Why You Should NOT Trade This Market (Ad)You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go ProShares UltraPro Short Nasdaq Biotechnology ExpensesTypeZBIOHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.56%0.55%0.49%0.52%Other Expenses1.02%0.33%0.49%0.41%0.54%Total Expense1.77%0.71%0.71%0.63%0.71%Fee Waiver-0.82%-0.45%-0.52%-0.33%-0.58%Net Expense0.95%0.61%0.61%0.56%0.59% Receive ZBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares UltraPro Short Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address ZBIO ETF News HeadlinesZenas BioPharma Announces Pricing of Upsized Initial Public OfferingSeptember 12, 2024 | globenewswire.comBullfrog AI Hldgs Stock (NASDAQ:BFRG), Quotes and News SummaryFebruary 25, 2023 | benzinga.com“I’ll Give You the Knowledge and Confidence You Need to Make Your First Options Trade in Five Days or Less… Guaranteed!”Starting Monday, September 23 — a veteran 25-year Chicago Options Exchange market-maker will show you his UOA options secret that could help you consistently target gains of 126%… 245%… even 463% or more… Often in 30 days or less… No matter what the market is doing right now.September 19, 2024 | InvestorPlace (Ad)ProFunds Short NASDAQ-100 SvcFebruary 16, 2023 | morningstar.comNasdaq Biotechnology Index NBISeptember 17, 2022 | wsj.comProShares UltraPro Short Nasdaq Biotechnology (ZBIO)August 23, 2022 | ca.finance.yahoo.comSee More Headlines ZBIO ETF - Frequently Asked Questions When did ProShares UltraPro Short Nasdaq Biotechnology IPO? ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) raised $225 million in an IPO on Friday, September 13th 2024. The company issued 13,235,294 shares at $17.00 per share. When does the company's quiet period expire? ProShares UltraPro Short Nasdaq Biotechnology's quiet period expires on Wednesday, October 23rd. ProShares UltraPro Short Nasdaq Biotechnology had issued 13,235,294 shares in its public offering on September 13th. The total size of the offering was $224,999,998 based on an initial share price of $17.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. What other stocks do shareholders of ProShares UltraPro Short Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraPro Short Nasdaq Biotechnology investors own include ProShares UltraPro Short QQQ (SQQQ), ProShares UltraPro QQQ (TQQQ), Immunomedics (IMMU), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Direxion Daily S&P Biotech Bull 3x Shares (LABU), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Direxion Daily Small Cap Bull 3X Shares (TNA). Fund Details IssuerProShares Fund NameProShares UltraPro Short Nasdaq Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:ZBIO Inception Date6/22/2015 Fund ManagerMichael Neches, Tarak Dave WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$2.85 million Average Daily Volume$25,501.70 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares250,000BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:ZBIO) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraPro Short Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraPro Short Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
